Viewing nowApito Tablet 20 Milligrams (Atorvastatin Calcium Trihydrate)
Atorvastatin Calcium Trihydrate 21.7mg
Tablet · Prescription medication
Nexpam Korea Co., Ltd.

MFDS item code 201602931 · Approved 2016.05.25 · Insurance code 662503460
Improvement of hyperlipidemia; prevention of cardiovascular diseases (such as myocardial infarction and stroke)
This medication reduces the risk of myocardial infarction and stroke in adults with risk factors for coronary heart disease and in patients with type 2 diabetes. It also helps to prevent hospitalization due to vascular procedures, chronic stable angina, and congestive heart failure. In patients with hyperlipidemia, it decreases total cholesterol, LDL-cholesterol, and triglyceride levels while increasing HDL-cholesterol levels. It is particularly effective in pediatric patients with heterozygous familial hypercholesterolemia, reducing the risk of cardiovascular diseases. This medication is used for the improvement of cardiovascular diseases and hyperlipidemia.
Patients receiving atorvastatin, both before and during treatment, should follow a standard cholesterol-lowering diet. This medication may be taken at any time of day, with or without food. 1. Hyperlipidemia The recommended initial dose is 10 mg of atorvastatin once daily. However, patients requiring greater reductions in LDL cholesterol may start with 20 mg or 40 mg once daily (only when a reduction of 45 % or more in LDL cholesterol is required). This medication is administered at a dose of 10 ~ 80 mg once daily. The initial and maintenance doses of this medication should be individualized according to the patient's characteristics, taking into consideration the treatment goal and response. Lipid levels should be analyzed within 2 ~ 4 weeks after starting treatment and/or titrating the dose, and the dose should be adjusted accordingly. Because the treatment goal is to lower LDL cholesterol, it is recommended to use LDL cholesterol at the start of treatment and when evaluating the treatment response. However, if LDL cholesterol levels are unavailable, total cholesterol should be used to monitor the treatment response. Patients with homozygous familial hypercholesterolemia The dose of this medication is 10 ~ 80 mg once daily. Administer this medication in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when such lipid-lowering treatments are not available. ○ Patients with renal impairment: Renal disease does not affect the plasma concentration of atorvastatin or its LDL cholesterol-lowering effect; therefore, no dose adjustment is necessary. ○ Older adults: The efficacy and safety in patients aged 70 years and older are generally similar to those in the usual adult patient population.
10 ~ 17 years: The recommended initial dose is 10 mg of this medication once daily, and the recommended maximum dose is 20 mg once daily.
If symptoms of muscular issues occur, this medication should be discontinued immediately. Particularly, if muscle pain or weakness is severe or if blood tests show significantly elevated muscle damage markers, medical consultation is necessary. Patients with liver dysfunction or liver diseases should not take this medication and should undergo regular liver function tests during treatment. This medication should not be used by pregnant women, women who may become pregnant, or breastfeeding women. It should not be administered to children, especially those under 10 years of age. Patients with a history of alcoholism, liver disease, impaired kidney function, and elderly patients should use this medication with extra caution. This medication may have an increased risk of side effects when taken with certain drugs, so inform healthcare providers of any other medications being taken. In particular, dosage adjustments may be required when taken with medications that interfere with the metabolism of this drug in the liver. If sudden symptoms such as muscle pain, weakness, or fever occur during treatment, contact a physician immediately for evaluation. This medication should be stored out of reach of children and kept in its original container for safety. There is no specific antidote for overdose, so treatment should involve monitoring liver function and muscle damage and addressing symptoms as they arise.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to protect it from air and moisture, preferably at room temperature between 1°C and 30°C. This will help maintain the efficacy of the medication for a longer period.
White round film-coated tablet
30 tablets/bottle, 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowAtorvastatin Calcium Trihydrate 21.7mg
Tablet · Prescription medication
Nexpam Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 21.7mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 43.4mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Kyungdong Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Shinil Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 10.845mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.